Results 81 to 90 of about 98,224 (178)

Life-Threatening Pneumonitis Related to Docetaxel Chemotherapy

, 2015
Development of pulmonary infiltrates with respiratory symptoms in patients with advanced cancer presents a diagnostic challenge. We describe a case of a patient who developed progressive respiratory failure and bilateral lung infiltrates whilst receiving
Eng Huat Tan MBBS, MMed (Int Med), MRCP (Int Med), FAMS (Med Oncol), Mei-Kim Ang MBBCh, MRCP, Quan Sing Ng MBBS, MRCP, Daniel Shao Weng Tan MBBS, Darren Wan Teck Lim MBBS, MRCP   +4 more
core   +1 more source

Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells

Journal of Experimental & Clinical Cancer Research
Background Immunotherapy has emerged as a promising approach in prostate cancer treatment, albeit with less efficacy compared to lung and esophageal cancers.
Ruoyang Liu, Long Zhang, Guoqing Xie, Xiang Li, Yu Liu, Ningyang Li, Aravind Raveendran, Yuankang Feng, Fubo Lu, Xiyue Deng, Junyi Li, Jinjian Yang, Zhenlin Huang, Zhankui Jia   +13 more
doaj   +1 more source

Molecular mechanisms of docetaxel resistance in breast cancer

, 2007
Docetaxel is a chemotherapy drug used to treat breast cancer, however as with many chemotherapeutic drugs, resistance commonly occurs and the underlying molecular mechanisms of drug resistance are not fully understood. Gene regulatory mechanisms like DNA
Kastl, Lena
core  

Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling. [PDF]

Curr Issues Mol Biol
Yang T, Chen X, Chu C, Wan Y.
europepmc   +1 more source

Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study. [PDF]

Jpn J Clin Oncol
Tsuru I, Taguchi S, Tanaka R, Kawai T, Kaneko T, Nakamura Y, Miyauchi Y, Hoshina H, Obinata D, Koshiba M, Shiozaki M, Takahashi J, Kano M, Naito A, Suda S, Noda M, Sugiyama N, Tanaka T, Uemura Y, Miyakawa J, Kamei J, Kakutani S, Niimi A, Yamada Y, Sato Y, Yamada Y, Nishimatsu H, Murata T, Takahashi S, Takada T, Akiyama Y, Takahashi S, Fujimura T, Fukuhara H, Nakagawa T, Kume H.   +35 more
europepmc   +1 more source

Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting. [PDF]

Cancers (Basel)
Alkan O, Nazlı İ, Başgöze A, Gümüş M.   +3 more
europepmc   +1 more source

Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer. [PDF]

Cancer Res
Zhou L, Murphy KC, Giwa HK, Hu K, Ma B, Brassil ML, Chang EH, DeMarco KD, Pradhan AJ, Sroka EM, Parikh CN, Mori H, Zhu LJ, Kelliher MA, Ruscetti M.   +14 more
europepmc   +1 more source

Docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction. [PDF]

Gynecol Oncol Rep
Ali M, Chua KJC, Chen H.
europepmc   +1 more source

AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial. [PDF]

Clin Cancer Res
Medina S, Tokuyama N, Putcha V, Pathak T, Fu P, Thomas H, Subhash VV, Yip S, Lin HM, Horvath LG, Kench JG, Zhang A, Stockler MR, Joshua AM, Azad A, Oakes SR, Davis ID, Sweeney CJ, Madabhushi A.   +18 more
europepmc   +1 more source

AOH1996, an Inhibitor of PCNA, Sensitises Breast Cancer Cells to Cytotoxic Chemotherapy. [PDF]

Breast Cancer (Dove Med Press)
Aiyappa-Maudsley R, Hughes TA.
europepmc   +1 more source